Ras subfamily

Apr 11, 2019

Qualigen Enters into Research Agreement for RAS Inhibitor Cancer Drug with University of Louisville (UofL)

Jan 17, 2019

Targovax Granted European Patent for Mutant-RAS Neoantigen Platform Lead Products

Jan 03, 2019

REVOLUTION Medicines to Present at the J.P. Morgan Healthcare Conference on January 8, 2019

Nov 19, 2018

Colorado Advanced Industries Awards Machavert $250K to Develop a Novel Therapeutics Against KRAS Cancers

Jun 19, 2018

Targovax Granted EU Patent for Mutant-RAS Neoantigen Platform 2nd Generation Product TG02

Apr 09, 2018

Intezyne Promotes Adam Carie, PhD to Director, Product Development

Jan 22, 2018

In Depth: Performance Comparison of OncoBEAM(TM) RAS CRC and Idylla(TM) ctKRAS Liquid Biopsy Testing for KRAS Mutation Detection Presented at ASCO GI 2018

Oct 02, 2017

New Research System Finds and Targets Vulnerabilities in Lung Cancer Cells

Jun 07, 2017

Potential Therapeutic Use of Exosomes Reported in NATURE